Gianluca Pirozzi

Director/Board Member bij TREX WIND-DOWN, INC.

Vermogen: 1 $ op 31-03-2024

47 jaar

Health Technology

Consumer Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Ed Sitar	M	63	TREX WIND-DOWN, INC.	4 jaar
Sean Christie	M	-	ALEXION PHARMACEUTICALS, INC.	3 jaar
Lubor Gaal	M	56	TREX WIND-DOWN, INC.	4 jaar
Piyush Sharma	M	-	ALEXION PHARMACEUTICALS, INC.	7 jaar
David Cohen	M	59	TREX WIND-DOWN, INC.	4 jaar
Sarah Marshall	F	-	ALEXION PHARMACEUTICALS, INC.	10 jaar
Christophe Hotermans	M	-	ALEXION PHARMACEUTICALS, INC.	4 jaar
Ruth Diazaraque	M	-	ALEXION PHARMACEUTICALS, INC.	1 jaar
Seng Cheng	M	-	ALEXION PHARMACEUTICALS, INC.	1 jaar
Jessica Bruno-Raiz	F	-	TREX WIND-DOWN, INC.	5 jaar
Glen Frick	M	57	ALEXION PHARMACEUTICALS, INC.	-
Nicola Heffron	F	52	ALEXION PHARMACEUTICALS, INC.	1 jaar
Morgan Sanford	F	-	ALEXION PHARMACEUTICALS, INC.	-
Tamar Thompson	F	50	ALEXION PHARMACEUTICALS, INC.	5 jaar
Patryk Mikucki	M	49	ALEXION PHARMACEUTICALS, INC.	-
Frédéric Chéreau	M	57	ALEXION PHARMACEUTICALS, INC.	2 jaar
Marc Dunoyer	M	71	ALEXION PHARMACEUTICALS, INC.	-
Todd Spalding	M	-	ALEXION PHARMACEUTICALS, INC.	-

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
David Brennan	M	70	ALEXION PHARMACEUTICALS, INC.	7 jaar
Zachary Rome	M	40	TREX WIND-DOWN, INC.	2 jaar
John Koconis	M	54	TREX WIND-DOWN, INC.	4 jaar
Joe Lucchese	M	57	TREX WIND-DOWN, INC.	4 jaar
Felix Baker	M	55	ALEXION PHARMACEUTICALS, INC.	6 jaar
Rana Strellis	F	-	ALEXION PHARMACEUTICALS, INC.	4 jaar
Christopher Coughlin	M	71	ALEXION PHARMACEUTICALS, INC.	7 jaar
Susan Altschuller	M	43	ALEXION PHARMACEUTICALS, INC.	2 jaar
Michael T. Stocum	M	58	TREX WIND-DOWN, INC.	-
Scott Peters	M	-	ALEXION PHARMACEUTICALS, INC.	8 jaar
Michael Ira Kenneth Elloian	M	52	ALEXION PHARMACEUTICALS, INC.	-
Ludwig Hantson	M	61	ALEXION PHARMACEUTICALS, INC.	4 jaar
Ebun Garner	M	52	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 jaar
Jack Mollen	M	73	ALEXION PHARMACEUTICALS, INC.	7 jaar
Brian Goff	M	55	ALEXION PHARMACEUTICALS, INC.	4 jaar
Judith Reinsdorf	F	60	ALEXION PHARMACEUTICALS, INC.	3 jaar
Paul Friedman	M	81	ALEXION PHARMACEUTICALS, INC.	4 jaar
Anne-Marie Law	F	56	ALEXION PHARMACEUTICALS, INC.	3 jaar
Ellen Chiniara	F	65	ALEXION PHARMACEUTICALS, INC.	3 jaar
Francois Nader	M	67	ALEXION PHARMACEUTICALS, INC.	4 jaar
Deborah Dunsire	M	61	ALEXION PHARMACEUTICALS, INC.	3 jaar
Linda A. Broenniman	F	67	TREX WIND-DOWN, INC.	-
Andreas Rummelt	M	66	ALEXION PHARMACEUTICALS, INC.	11 jaar
Thierry Chauche	M	48	ALEXION PHARMACEUTICALS, INC.	-
Ai Min Hui	M	61	Sanofi SA	2 jaar
Angela Giannantonio	F	-	ALEXION PHARMACEUTICALS, INC.	-
Shane Doyle	M	-	ALEXION PHARMACEUTICALS, INC.	7 jaar
Megan Goulart	F	-	ALEXION PHARMACEUTICALS, INC.	-
Kristen Stants	F	51	ALEXION PHARMACEUTICALS, INC.	2 jaar
Adam Hansard	M	48	ALEXION PHARMACEUTICALS, INC.	1 jaar
Christopher Wick	M	-	ALEXION PHARMACEUTICALS, INC.	4 jaar
Alexandra Kropotova	M	51	Sanofi SA	9 jaar
Christopher Sorli	M	-	Sanofi SA	4 jaar
Uzair Qadeer	M	-	ALEXION PHARMACEUTICALS, INC.	2 jaar
Becky Lillie	F	-	ALEXION PHARMACEUTICALS, INC.	-
Rosemary Harrison	M	41	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 jaar
Alan Mendelsohn	M	62	TREX WIND-DOWN, INC.	3 jaar
Julia Wang	F	53	ALEXION PHARMACEUTICALS, INC.	2 jaar
Martine Zimmermann	M	55	ALEXION PHARMACEUTICALS, INC.	7 jaar
Holly Schachner	M	57	Sanofi SA	5 jaar
Sandra Jonsson	M	51	ALEXION PHARMACEUTICALS, INC.	-
Christopher Benecchi	M	-	ALEXION PHARMACEUTICALS, INC.	2 jaar
Michael Lisjak	M	50	Sanofi SA	1 jaar
Patrick Barry	M	-	Sanofi SA	24 jaar
Ann Miller	M	66	Sanofi SA	6 jaar
Amir Tavakkol	M	69	TREX WIND-DOWN, INC.	1 jaar
Paul Sekhri	M	66	Sanofi SA	1 jaar
Heidi Henson	F	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 jaar
Laurie Keating	F	70	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	1 jaar
Christopher J. Stevo	M	-	ALEXION PHARMACEUTICALS, INC.	1 jaar
Michael Derby	M	51	TREX WIND-DOWN, INC.	2 jaar
Paul Clancy	M	62	ALEXION PHARMACEUTICALS, INC.	2 jaar
Emmanuel Babeau	M	57	Sanofi SA	2 jaar
Steven M. Bosacki	M	66	TREX WIND-DOWN, INC.	-
Tanisha Cariño	M	49	ALEXION PHARMACEUTICALS, INC.	2 jaar
Indrani Franchini	F	52	ALEXION PHARMACEUTICALS, INC.	4 jaar
H. Cohen	M	58	Imbria Pharmaceuticals, Inc. Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.	-
John V. W. Reynders	M	-	ALEXION PHARMACEUTICALS, INC.	6 jaar
Vincent O'Neill	M	55	Sanofi SA	2 jaar
John Orloff	M	66	ALEXION PHARMACEUTICALS, INC.	4 jaar
Dieter Weinand	M	63	Sanofi SA	2 jaar
Jose Menoyo	M	-	ALEXION PHARMACEUTICALS, INC.	3 jaar
Desiree Luthman	M	65	Sanofi SA	2 jaar
Ching Jaw	M	61	Sanofi SA	2 jaar
Michael Kaseta	M	48	Sanofi SA	11 jaar
Daniel A. Bazarko	M	-	ALEXION PHARMACEUTICALS, INC.	9 jaar
Tsveta Milanova	F	47	ALEXION PHARMACEUTICALS, INC.	2 jaar
Laura Gault	F	-	ALEXION PHARMACEUTICALS, INC.	3 jaar

Statistieken

Land	Connecties	% van het totaal
Verenigde Staten	72	83.72%
Frankrijk	14	16.28%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Gianluca Pirozzi
Persoonlijk netwerk